<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T04:29:42Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5851600" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:5851600</identifier>
        <datestamp>2018-03-14</datestamp>
        <setSpec>nihpa</setSpec>
        <setSpec>pmc-open</setSpec>
        <setSpec>manuscript</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-journal-id">101242342</journal-id>
              <journal-id journal-id-type="pubmed-jr-id">32406</journal-id>
              <journal-id journal-id-type="nlm-ta">Contemp Clin Trials</journal-id>
              <journal-id journal-id-type="iso-abbrev">Contemp Clin Trials</journal-id>
              <journal-title-group>
                <journal-title>Contemporary clinical trials</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1551-7144</issn>
              <issn pub-type="epub">1559-2030</issn>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC5851600</article-id>
              <article-id pub-id-type="pmcid">PMC5851600</article-id>
              <article-id pub-id-type="pmc-uid">5851600</article-id>
              <article-id pub-id-type="pmid">29287665</article-id>
              <article-id pub-id-type="pmid">29287665</article-id>
              <article-id pub-id-type="doi">10.1016/j.cct.2017.12.016</article-id>
              <article-id pub-id-type="manuscript">nihpa949705</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Tobacco dependence treatment in the emergency department: A randomized trial using the Multiphase Optimization Strategy</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bernstein</surname>
                    <given-names>Steven L.</given-names>
                  </name>
                  <xref ref-type="aff" rid="A1">a</xref>
                  <xref ref-type="aff" rid="A2">b</xref>
                  <xref ref-type="aff" rid="A3">c</xref>
                  <xref rid="FN1" ref-type="author-notes">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dziura</surname>
                    <given-names>James</given-names>
                  </name>
                  <xref ref-type="aff" rid="A1">a</xref>
                  <xref ref-type="aff" rid="A2">b</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Weiss</surname>
                    <given-names>June</given-names>
                  </name>
                  <xref ref-type="aff" rid="A1">a</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Miller</surname>
                    <given-names>Ted</given-names>
                  </name>
                  <xref ref-type="aff" rid="A4">d</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Vickerman</surname>
                    <given-names>Katrina A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="A5">e</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Grau</surname>
                    <given-names>Lauretta E.</given-names>
                  </name>
                  <xref ref-type="aff" rid="A2">b</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pantalon</surname>
                    <given-names>Michael V.</given-names>
                  </name>
                  <xref ref-type="aff" rid="A1">a</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Abroms</surname>
                    <given-names>Lorien</given-names>
                  </name>
                  <xref ref-type="aff" rid="A6">f</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Collins</surname>
                    <given-names>Linda M.</given-names>
                  </name>
                  <xref ref-type="aff" rid="A7">g</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Toll</surname>
                    <given-names>Benjamin</given-names>
                  </name>
                  <xref ref-type="aff" rid="A3">c</xref>
                  <xref ref-type="aff" rid="A8">h</xref>
                </contrib>
              </contrib-group>
              <aff id="A1"><label>a</label>Department of Emergency Medicine, Yale School of Medicine, United States</aff>
              <aff id="A2"><label>b</label>Department of Health Policy, Yale School of Public Health, United States</aff>
              <aff id="A3"><label>c</label>Yale Cancer Center, New Haven, CT, United States</aff>
              <aff id="A4"><label>d</label>Pacific Institute of Research and Evaluation, Calverton, MD, United States</aff>
              <aff id="A5"><label>e</label>Alere Wellbeing, Seattle, WA, United States</aff>
              <aff id="A6"><label>f</label>Department of Prevention and Community Health, Milken Institute School of Public Health at George Washington University, United States</aff>
              <aff id="A7"><label>g</label>The Methodology Center and Department of Human Development and Family Studies, Pennsylvania State University, College Station, PA, United States</aff>
              <aff id="A8"><label>h</label>Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, United States</aff>
              <author-notes>
                <corresp id="FN1"><label>*</label>Corresponding author at: Department of Emergency Medicine, Yale School of Medicine, 464 Congress Ave., Suite 260, New Haven, CT 06519, United States. <email>Steven.bernstein@yale.edu</email> (S.L. Bernstein)</corresp>
              </author-notes>
              <pub-date pub-type="nihms-submitted">
                <day>9</day>
                <month>3</month>
                <year>2018</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>27</day>
                <month>12</month>
                <year>2017</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <month>3</month>
                <year>2018</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>14</day>
                <month>3</month>
                <year>2018</year>
              </pub-date>
              <volume>66</volume>
              <fpage>1</fpage>
              <lpage>8</lpage>
              <!--elocation-id from pubmed: 10.1016/j.cct.2017.12.016-->
              <permissions>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the CC BY-NC-ND license (<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">http://creativecommons.org/licenses/BY-NC-ND/4.0/</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <sec id="S1">
                  <title>Background</title>
                  <p id="P1">Tobacco dependence remains the leading preventable cause of death in the developed world. Smokers are disproportionately from lower socioeconomic groups, and may use the hospital emergency department (ED) as an important source of care. A recent clinical trial demonstrated the efficacy of a multicomponent intervention to help smokers quit, but the independent contributions of those components is unknown.</p>
                </sec>
                <sec id="S2">
                  <title>Methods</title>
                  <p id="P2">This is a full-factorial (16-arm) randomized trial in a busy hospital ED of 4 tobacco dependence interventions: brief motivational interviewing, nicotine replacement therapy, referral to a telephone quitline, and a texting program. The trial utilizes the Multiphase Optimization Strategy (MOST) and a novel mixed methods analytic design to assess clinical efficacy, cost effectiveness, and qualitative participant feedback. The primary endpoint is tobacco abstinence at 3 months, verified by participants’ exhaled carbon monoxide.</p>
                </sec>
                <sec id="S3">
                  <title>Results</title>
                  <p id="P3">Study enrollment began in February 2017. As of April 2017, 52 of 1056 planned participants (4.9%) were enrolled. Telephone-based semi-structured participant interviews and in-person biochemical verification of smoking abstinence are completed at the 3-month follow-up. Efficacy and cost effectiveness analyses will be conducted after follow-up is completed.</p>
                </sec>
                <sec id="S4">
                  <title>Discussion</title>
                  <p id="P4">The goal of this study is to identify a clinically efficacious, cost-effective intervention package for the initial treatment of tobacco dependence in ED patients. The efficacy of this combination can then be tested in a subsequent confirmatory trial. Our approach incorporates qualitative feedback from study participants in evaluating which intervention components will be tested in the future trial.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>Smoking cessation</kwd>
                <kwd>Tobacco dependence treatment</kwd>
                <kwd>Emergency department</kwd>
                <kwd>Mixed methods</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="S5">
              <title>1. Introduction</title>
              <p id="P5">Fifty years after the landmark 1964 Surgeon General’s report, smoking remains the leading cause of preventable death in the United States, with about 480,000 deaths per year [<xref rid="R1" ref-type="bibr">1</xref>]. In 2012, $289 billion in direct and indirect costs were associated with tobacco use. In 2015, 15.1% of Americans smoked [<xref rid="R2" ref-type="bibr">2</xref>], still far short of the Healthy People 2020 goal of 12% prevalence [<xref rid="R3" ref-type="bibr">3</xref>]. Certainly, significant progress has been made, with the prevalence of smoking among U.S. adults reduced from 42% in 1964. However, after half a century of research, regulation, policy advances, drug development, public service campaigns, and litigation, significant challenges in treating tobacco remain. Smoking is an addiction that has become increasingly disproportionate among the medically disadvantaged: those with low income or low education, the mentally ill, and individuals with other substance use disorders. These are among the groups identified in a 2006 NIH State-of-the-Science conference as those most in need of advances in treatment and treatment engagement [<xref rid="R4" ref-type="bibr">4</xref>].</p>
              <p id="P6">These groups of smokers are commonly treated in hospital emergency departments (EDs). EDs are a frequent site of care for all Americans, with approximately 136 million visits across 4000 EDs in 2011 [<xref rid="R5" ref-type="bibr">5</xref>]. ED patients are disproportionately of low socioeconomic status, more likely to smoke compared with the general population, [<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R7" ref-type="bibr">7</xref>] and more likely to have limited or irregular access to primary care. ED smokers often present with illnesses caused or exacerbated by tobacco use or have injuries (e.g., lacerations, fractures) for which smoking impedes their healing [<xref rid="R8" ref-type="bibr">8</xref>–<xref rid="R10" ref-type="bibr">10</xref>]. Hence the ED visit represents an opportune time to discuss patients’ tobacco use, its relevance to their current visit, and to initiate tobacco treatment and aftercare [<xref rid="R11" ref-type="bibr">11</xref>]. This represents an evolving standard of treatment in the ED care of the patient who smokes [<xref rid="R12" ref-type="bibr">12</xref>].</p>
              <p id="P7">Our group has recently demonstrated the efficacy of a multi-component intervention that includes behavioral and pharmacologic therapies in promoting tobacco abstinence among ED smokers [<xref rid="R10" ref-type="bibr">10</xref>]. In a randomized trial of 778 smokers, a combination of brief motivational interviewing, six weeks of nicotine patches and gum, referral to a smokers’ quitline, and a follow-up phone call resulted in a significant improvement in the three-month, biochemically confirmed abstinence rate: 12.2% vs. 4.9% [<xref rid="R10" ref-type="bibr">10</xref>]. Our model adapts the treatment paradigm known as Screening, Brief Intervention, and Referral to Treatment (SBIRT) [<xref rid="R13" ref-type="bibr">13</xref>]. The components of our intervention were: a brief adaptation of motivational interviewing (MI), called the Brief Negotiation Interview [<xref rid="R14" ref-type="bibr">14</xref>], initiation of nicotine replacement therapy (NRT) in the ED with provision of a 6-week supply of patches and gum, referral to the Connecticut State smokers’ telephone quitline (QL), provision of a smoking cessation brochure, and the provision of a booster phone call 3 days after enrollment [<xref rid="R10" ref-type="bibr">10</xref>]. Recent pilot studies conducted by our group showed the feasibility and potential efficacy of ED-initiated short-message-service (SMS) for tobacco dependence treatment [<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref>].</p>
              <p id="P8">One limitation of our work is that we cannot disentangle the contribution to abstinence of the individual components of the intervention. We assume that each is important, but we cannot model their contributions, or whether important interactions exist. It is therefore imperative to identify the most clinically effective and cost-effective components to create an efficacious intervention that can be delivered for the lowest cost possible in real-world ED settings.</p>
              <sec id="S6">
                <title>1.1. Trial objectives</title>
                <p id="P9">The goal of this study is to identify components of an ED-based intervention which are optimally effective for treating adult smokers.</p>
              </sec>
            </sec>
            <sec sec-type="methods" id="S7">
              <title>2. Methods</title>
              <sec id="S8">
                <title>2.1. Overview and study design</title>
                <p id="P10">The MOST design, developed by Collins and outlined in <xref rid="F1" ref-type="fig">Fig. 1</xref>, is an iterative process that often employs a factorial design (Optimization) followed by a traditional randomized clinical trial (Evaluation), that allows investigators to efficiently identify efficacious components of an intervention, subject to a cost constraint [<xref rid="R17" ref-type="bibr">17</xref>–<xref rid="R21" ref-type="bibr">21</xref>]. Intervention components may be studied in a full- or reduced-factorial design. MOST has been used to design interventions to treat tobacco dependence [<xref rid="R21" ref-type="bibr">21</xref>,<xref rid="R22" ref-type="bibr">22</xref>], but, to our knowledge, has not been previously used in the ED setting.</p>
                <p id="P11">Our group’s work in ED-initiated tobacco dependence treatment conducted to date would constitute the Preparation phase. MOST has been used in a number of smoking cessation trials [<xref rid="R22" ref-type="bibr">22</xref>–<xref rid="R25" ref-type="bibr">25</xref>], but not in the ED. MOST borrows 2 principles from engineering: (1) the resource management principle, which says that research resources should be managed strategically to maximize information gain in a timely fashion, and (2) continuous optimization, which says that a new cycle of research should begin soon after conclusion of the previous cycle, employing the information gained from that cycle [<xref rid="R25" ref-type="bibr">25</xref>].</p>
                <p id="P12">Our study will use a full 2 [<xref rid="R4" ref-type="bibr">4</xref>] (i.e. 16-arm) factorial design to evaluate the effects of 4 intervention components at a fraction of the cost, using one-fourth of the participants it would take to conduct 4 individual experiments to evaluate each component separately. <xref rid="T1" ref-type="table">Table 1</xref> outlines the 16 arms.</p>
                <p id="P13">In addition, qualitative participant interviews will provide a nuanced understanding of how patients’ perceptions about using the various components and contextual factors may influence the feasibility of implementation. These perceptions and contextual factors may not otherwise be captured by traditional survey methods, and are therefore included in our mixed methods approach to improve the readiness of the final treatment package for real-world implementation. A subsequent traditional randomized trial is planned as a future study, which will require additional external support.</p>
                <p id="P14">Our multicomponent intervention consists of the following: (1) a Brief Negotiation Interview (our brief adaptation of motivational interviewing [<xref rid="R26" ref-type="bibr">26</xref>]), delivered by a trained staff member; (2) provision of 6 weeks of nicotine patches and gum to the research participant, with application of the first patch in the ED; (3) active referral to the Connecticut Smokers’ Quitline; and (4) enrollment in the SmokefreeTXT short-messaging service (SMS) texting program for mobile phones. All patients will receive the smoking cessation brochure. Using MOST principles, the screening phase will use a 2× 2× 2× 2 full-factorial design to identify the components most likely to be efficacious in combination. Although the factorial design requires the allocation of participants to 16 different combinations of the 4 components (<xref rid="T1" ref-type="table">Table 1</xref>), evaluation of each individual component is performed comparing all of those receiving a component to all of those not receiving a component, making this an efficient design. For instance, evaluation of the BNI component will compare those randomized to conditions 1 through 8 to those in conditions 9 to 16. Based on the results of the screening phase in conjunction with findings from the qualitative analysis, we will design and propose a 2-arm randomized clinical trial comparing the efficacy of the multicomponent intervention package to usual care for the confirmatory phase.</p>
              </sec>
              <sec id="S9" sec-type="subjects">
                <title>2.2. Participants</title>
                <sec id="S10">
                  <title>2.2.1. Inclusion criteria</title>
                  <p id="P15">Patients who present to the adult ED at Yale-New Haven Hospital (YNHH) are eligible for the study if they are: (1) 18 years or older (2) have smoked at least 100 cigarettes in their lifetime (3) describe themselves as every-day or some-day smokers (4) smoke at least 5 cigarettes/day, on average (5) own a cellphone with texting capability, and (6) are able to give written informed consent.</p>
                </sec>
                <sec id="S11">
                  <title>2.2.2. Exclusion criteria</title>
                  <p id="P16">Patients are excluded for: (1) not being able to read or understand English; (2) currently receiving formal tobacco dependence treatment; (3) having a life-threatening or unstable medical, surgical, or psychiatric condition; (4) being unable to provide at least one collateral contact; (5) living out-of-state; (6) planning to leave the ED against medical advice (7) being pregnant (self-report or urine testing) or currently nursing or trying to conceive.</p>
                </sec>
              </sec>
              <sec id="S12">
                <title>2.3. Setting</title>
                <p id="P17">YNNH is part of an academic medical center that serves a moderately poor city in the northeastern United States; in 2015, 26.6% of New Haven’s 130,000 residents lived in poverty [<xref rid="R27" ref-type="bibr">27</xref>]. In 2013, women represented approximately 55% of the ED population; the mean age of ED adults was 41 years. The racial mix of our patients reflects that of New Haven: 65% White, not Hispanic; 23% African-American, not Hispanic, 10% Hispanic; 2% other. Payor status for ED smokers is approximately 55% Medicaid, 5% Medicare, 30% private insurance, and 10% self-pay. The Adult ED is a level one trauma center that treats 92,000 adult visits per year. The prevalence of smoking in the city is 18%, slightly above the national average [<xref rid="R28" ref-type="bibr">28</xref>].</p>
              </sec>
              <sec id="S13">
                <title>2.4. Screening procedures and recruitment</title>
                <p id="P18">Participants are being recruited during all days of the week from 8 am-10 pm. Potential participants will meet with a research assistant to be evaluated for eligibility. Patients are asked for verbal consent to complete the 2-item tobacco screener used by the Behavioral Risk Factor Surveillance System (Do you smoke cigarettes every day, some days, or not at all? Have you smoked at least 100 cigarettes in your entire life?). Patients who report smoking but are not eligible are given a handout recommending that they abstain from smoking, contact their primary care provider, and consider calling the quitline. Individuals who meet inclusion and exclusion criteria and consent to participate have baseline assessments performed and are then randomized to one of 16 combinations of components (<xref rid="T1" ref-type="table">Table 1</xref>).</p>
              </sec>
              <sec id="S14">
                <title>2.5. Randomization</title>
                <p id="P19">To assure equal intervention allocation and concealment of intervention allocation a random permuted block sequence was generated (via <ext-link ext-link-type="uri" xlink:href="www.randomization.com">www.randomization.com</ext-link>) and intervention assignments distributed through the clinical trial data management system.</p>
              </sec>
              <sec id="S15">
                <title>2.6. Interventions</title>
                <p id="P20">Our previous work employed a multicomponent approach to ED-initiated tobacco treatment, which used both pharmacologic and behavioral approaches. All components are evidence-based; most are cited in the 2008 Public Health Service clinical practice guideline [<xref rid="R29" ref-type="bibr">29</xref>]. The newest approach, text messaging on mobile phones, is supported by a Cochrane review [<xref rid="R30" ref-type="bibr">30</xref>]. Below we discuss these components, the rationale for each, and supportive evidence. Our intent is to use the MOST approach to identify the individual contributions of these components and to assemble them into an intervention that is effective, efficient, and scalable.</p>
                <sec id="S16">
                  <title>2.6.1. Brief Negotiation Interview (BNI)</title>
                  <p id="P21">Brief Negotiation Intervention (BNI) is a manual-guided brief intervention that is an adaptation of motivational interviewing and has been shown to be feasible and efficacious in the ED setting. The BNI manual for this study is based on one that we used in our previous trial. The purpose of the BNI is to assist patients in recognizing the problematic nature of and changing their tobacco use. The main goals of the interview are to elicit disincentives for smoking and compelling personal reasons/motives for quitting from the patient, thereby motivating them to change their smoking behavior by reducing the number of cigarettes smoked daily or abstaining completely. The 4 steps of the BNI are: 1) Raising the subject, 2) Providing feedback, 3) Enhancing motivation and 4) Negotiating a plan.</p>
                  <p id="P22">The BNI is delivered and audiotaped by trained RAs who have a bachelor’s-level education. Tapes are reviewed biweekly by the RAs and a clinical psychologist to assess fidelity to the scripted BNI protocol. In our prior work, the BNIs average 10–15 min in length. RAs received 10 h of training in our manualized BNI. The training included role-play of patient scenarios, followed by 1 week of shadowing an experienced RA performing BNIs on ED patients. These procedures were used successfully in our prior study [<xref rid="R10" ref-type="bibr">10</xref>].</p>
                  <p id="P23">If, during the BNI or other interactions, the participant discloses to the RA risky behaviors such as suicidality, intimate partner violence, or use of other substances, the RA notifies the treating ED physician.</p>
                </sec>
                <sec id="S17">
                  <title>2.6.2. Nicotine gum and patch, with initial dose in the ED</title>
                  <p id="P24">Participants randomized to NRT receive 6 weeks of patches (42 count) and gum (300 pieces of 2 mg). NRT dosing is tailored to the participant’s cigarette consumption (5–10 cigarettes/day: 14 mg patch and 2 mg gum;&gt; 10 cigarettes/day: 21 mg patch and 2 mg gum). Patches come in 14 and 21 mg doses. The first patch is applied by an ED nurse at the index visit. The RA then conducts a brief educational session with the participant on the use of both the patch and the gum. This approach, which employs immediate cessation of tobacco, stands in contrast to the traditional model of setting a quit date several weeks after the initiation of tobacco dependence treatment. In our previous investigation, this approach was accepted enthusiastically by study participants. Combination NRT is provided because it is generally more efficacious than NRT monotherapy in promoting tobacco abstinence [<xref rid="R29" ref-type="bibr">29</xref>].</p>
                </sec>
                <sec id="S18">
                  <title>2.6.3. Text messaging</title>
                  <p id="P25">We are using the SmokefreeTXT program, developed by the National Cancer Institute of the NIH and available through Smokefree. gov. SmokefreeTXT is a text messaging service designed for U.S. adults who are trying to quit smoking. The program provides 24/7 encouragement, advice, and tips to help smokers quit, and stay quit. Messages are timed around the quit date, and the program lasts 6–8 weeks depending on chosen quit date. Users receive 1–5 messages per day and can receive additional quit support by texting one of SmokefreeTXT’s keywords.</p>
                  <p id="P26">The SmokefreeTXT library contains about 130 messages. In the previous pilot study, a modest number of modifications were made and primarily concerned time considerations (e.g., deletion of all messages concerning the 2-week lead-in to the actual quit date) and tailoring information to local resources for Connecticut residents. SmokeFreeTXT employs a number of behavior change strategies, including feedback and monitoring, social support, and shaping knowledge [<xref rid="R31" ref-type="bibr">31</xref>]. Based on the qualitative data we collected during our pilot study [<xref rid="R16" ref-type="bibr">16</xref>], we offer participants in the current trial a choice of how many messages they receive per day (up to 2 messages or up to 4 messages per day) and the time of day they receive the first message. We also added 18 messages for participants presenting to the ED with specific chief complaints (cardiac, respiratory, or wound care) during the index visit.</p>
                </sec>
                <sec id="S19">
                  <title>2.6.4. Active quitline referral</title>
                  <p id="P27">Participant information is faxed to the Connecticut QL’s service provider, Alere Wellbeing. QL staff then makes outbound calls to reach participants, provide information about services standardly offered by the Connecticut QL, and enroll interested participants in QL services. The Connecticut QL currently offers residents the option of enrolling in a one call, multiple call, or web-based tobacco cessation program. All enrollees in the multiple call or web-based programs who meet medical screening criteria are also eligible for two weeks of the nicotine patch, gum or lozenge mailed from the QL. The call programs combine individualized telephone counseling, text messaging, mailed or online materials, and an interactive online program to complement the phone-based program. After the initial assessment and planning call, participants in the multiple call program receive 4 additional proactive counseling calls. Calls are designed to help participants set a quit date, design a plan for cessation, develop problem-solving and coping skills, secure social support, and effectively use cessation medications, such as NRT. Quit coaches are required to have a bachelor’s degree, complete over 200 h of education and training in tobacco cessation treatment, and receive ongoing supervision. Calls are scheduled at convenient times and at relapse-sensitive intervals; calls in the multiple call program are typically completed within 2–3 months of program registration. Participants can also call for additional support between proactive calls. The Alere program is based on the 2008 Public Health Service clinical practice guideline [<xref rid="R29" ref-type="bibr">29</xref>] and grounded in Social Cognitive Theory [<xref rid="R32" ref-type="bibr">32</xref>]. Its effectiveness has been validated by 3 randomized trials [<xref rid="R33" ref-type="bibr">33</xref>–<xref rid="R35" ref-type="bibr">35</xref>], and several real-world evaluations [<xref rid="R36" ref-type="bibr">36</xref>–<xref rid="R38" ref-type="bibr">38</xref>]. In our prior study, 32% of participants in the intervention arm engaged in ≥1 call with the quitline [<xref rid="R39" ref-type="bibr">39</xref>].</p>
                  <p id="P28">Lastly, all participants are provided with a brochure that reviews the health hazards of smoking, and provides the phone number for the state quitline. In Connecticut, this brochure is produced by the State Department of Public Health, printed in English and Spanish, and is available in bulk at low cost. We believe that distributing this brochure to all study participants is reasonable and ethical. Because provision of the brochure is not manipulated in the experiment we will be unable to isolate any discrete effect of the brochure on tobacco abstinence.</p>
                </sec>
              </sec>
              <sec id="S20">
                <title>2.7. Primary outcome measure</title>
                <p id="P29">The primary efficacy endpoint is biochemically verified 7-day cessation at 3 months [<xref rid="R40" ref-type="bibr">40</xref>]. Tobacco cessation will be assessed by self-report and confirmatory biochemical testing with exhaled carbon monoxide. Patients who assert abstinence by phone interview will be asked to return to the hospital for biochemical assessment of exhaled carbon monoxide.</p>
              </sec>
              <sec id="S21">
                <title>2.8. Secondary outcome measures</title>
                <p id="P30">Secondary outcomes include use of cessation medications and services, including use of the quitline, use of NRT, and use of other pharmacotherapies such as bupropion and varenicline, as well as changes in daily cigarette consumption. These will be assessed by self-report and fax reports from the CT quitline. A brief, structured interview called the Treatment Service Review (TSR) [<xref rid="R41" ref-type="bibr">41</xref>] will be administered to collect information on the type and amount of services received by participants, including ED visits, hospitalizations, primary medical care visits, quitline utilization, and self-help sources of support (e.g. web services). The TSR will be supplemented with questions on the use of smoking cessation medications.</p>
              </sec>
              <sec id="S22">
                <title>2.9. Analytic strategy</title>
                <sec id="S23">
                  <title>2.9.1. Overview</title>
                  <p id="P31">Intervention components will be analyzed over 3 domains, as outlined in <xref rid="F2" ref-type="fig">Fig. 2</xref>. First, components will be assessed for clinical efficacy, using traditional measures such as biochemically verified tobacco abstinence. If clinically effective, components will then be analyzed for cost-effectiveness and feasibility/acceptability to participants.</p>
                </sec>
              </sec>
              <sec id="S24">
                <title>2.10. Assessing clinical efficacy</title>
                <p id="P32">Participants will be contacted by telephone at 1 and 3 months after enrollment. At 3 months, participants self-reporting tobacco abstinence will be asked to return to the hospital to measure exhaled carbon monoxide (CO). Participants whose breath CO levels are 9 ppm or less will be considered abstinent [<xref rid="R40" ref-type="bibr">40</xref>].</p>
                <p id="P33">Multivariable logistic regression will be used to model the primary outcome, abstinence at 3 months. Per convention, in the primary analysis missing abstinence data, including absence of biochemical verification, will be coded as smoking. For this full-factorial design, the model will include main effects for each of the 4 components as well as all 2, 3 and 4-way interactions. The regression will also include baseline covariates: age, sex, race/ethnicity, and smoking characteristics, such as daily cigarette consumption. Main effects will be evaluated at the 0.05 significance level. Differences in proportions for the presence and absence of each component (i.e. main effects) will be estimated along with 95% confidence intervals using the bootstrap method [<xref rid="R42" ref-type="bibr">42</xref>]. A <italic>p-</italic>value of 0.10 will be used as a guide to flag potentially important interactions which will be explored graphically with a particular emphasis on identifying substantial synergistic effects or qualitative (i.e. where the impact of 1 component changes direction depending on the presence or absence of another component) effect modification. Similar analyses will be performed at 1-month follow-up. Additionally, a logistic regression with parameters estimated by weighted Generalized Estimating Equations (GEE) will incorporate both 1- and 3-month outcome data without imputing non-responders as relapse [<xref rid="R43" ref-type="bibr">43</xref>]. This analysis weights for the probability of response and is valid under the assumption that missing data are missing at random. Secondary outcomes at 1 and 3 months will also be evaluated by a generalized linear model with weighted GEE.</p>
              </sec>
              <sec id="S25">
                <title>2.11. Justification of sample size</title>
                <p id="P34">The goal of this proposal is to identify individual tobacco dependence treatment intervention components which show clinical efficacy, subject to constraints of cost effectiveness and acceptability. As each component is allocated to half the participants, the sample size to detect main effects in a full factorial MOST design depends not on the number of components evaluated, but rather the smallest clinically important difference between the presence and absence of a component. In our previous trial, we found a difference of 7.3% in biochemically confirmed abstinence between the control and intervention arms at 3 months. It is reasonable to expect that, in this factorial trial, the effect of individual components will be less than that seen in the multi-component trial [<xref rid="R17" ref-type="bibr">17</xref>,<xref rid="R44" ref-type="bibr">44</xref>]. Therefore, we have chosen an absolute difference of 5% for the main effects of each component. (We considered a narrower difference of 4%, but the sample size and resources needed become unfeasible.) With a two-sided 0.05 significance level, and an average abstinence proportion of 4.9% in the absence of a component, a total sample size of 860 participants will provide 80% power to detect a 5% increase in the abstinence rate. We will enroll 1056 participants to account for a 15% dropout rate by 3 months. We will investigate whether the effect of a component is dependent on the levels of other components (i.e. interactions), but our trial is not powered with the intent to detect these interactions.</p>
              </sec>
              <sec id="S26">
                <title>2.12. Assessing cost effectiveness</title>
                <sec id="S27">
                  <title>2.12.1. Overview</title>
                  <p id="P35">We will perform a series of incremental cost effectiveness analyses (CEA) to determine whether the benefits of each component appear to be worth the added costs, partially accounting for the interactive effects of the components. Two outcomes will be considered: (1) number of abstinent smokers at 3 months (measured by biochemically verified 7-day tobacco abstinence) and (2) the cost per QALY saved. Following CEA recommendations [<xref rid="R45" ref-type="bibr">45</xref>,<xref rid="R46" ref-type="bibr">46</xref>], baseline analyses will adopt a societal perspective, considering all economic costs regardless of source. We also will calculate incremental cost effectiveness ratios (ICERs) from the payer’s perspective, excluding patient costs and, in sensitivity analysis, QL costs. We will use ICERs for other cessation interventions to select an acceptable maximum cost/quality-adjusted life year (QALY) saved for the tested program elements since we want to identify an ED cessation approach that is at least as cost-effective as approaches based in other settings [<xref rid="R47" ref-type="bibr">47</xref>–<xref rid="R49" ref-type="bibr">49</xref>].</p>
                </sec>
                <sec id="S28">
                  <title>2.12.2. Treatment costs</title>
                  <p id="P36">We will include costs of all smoking cessation treatment received by participants, broken down by component (<xref rid="T2" ref-type="table">Table 2</xref>). Resource costs include costs of administering the BNI and medication (a purchased item), administering the texting, and making the QL referral (i.e., IT costs, cost of clinician time to administer the intervention, medication delivered in hospital, incremental cost of longer follow-up booster phone call), costs related to QL use, outpatient treatment costs, other medical costs, and patient costs (e.g., time, transportation). In evaluating a prior trial, we measured RA time for an ED-based BNI session. Clinician time costs will include wages, fringe benefits, and overhead. Cost of patient time will be calculated using the average wage rate in the geographic area. Relevant medication use will be obtained from the medical record; cost of medication will be based on the average of the current formulary price for the top 5 health insurers in Connecticut. Quitline costs: We will get the number of counseling calls completed directly from QL records, then calculate costs of counselor and patient time related to the calls (both scheduled QL calls and participant-initiated calls). We will collect patient time on the website at 1 and 3 month assessments, as well as costs of any NRT shipped, and registration costs for quitline-managed web or texting services. We will exclude research costs because these would not be incurred if our intervention were standard care. Training and texting program setup costs will be excluded from the main analyses. Although these startup costs may be incurred, when distributed across many patients over many years, they would be negligible. We will collect information on training and setup costs and include in publications/sensitivity analysis, as these may be of interest to decision makers.</p>
                </sec>
                <sec id="S29">
                  <title>2.12.3. Measuring effectiveness</title>
                  <p id="P37">We will assess effectiveness (i.e., abstinence) biochemically at 3 months. With the MOST design, regression will estimate quit rates for the 4 potential intervention components, as well as the gains and losses that occur when combining them. Over time, abstinence reduces medical care utilization and improves quality of life. We will not track those savings in our patient cohort. Instead, we will update our adaptation of a popular model that simulates them [<xref rid="R50" ref-type="bibr">50</xref>].</p>
                </sec>
                <sec id="S30">
                  <title>2.12.4. Calculating cost effectiveness ratios</title>
                  <p id="P38">We will calculate incremental cost effectiveness ratios (ICERs) in 2 passes. A naive first pass will array cost and regression-adjusted quit rate for each of the 16 MOST cells, ignoring if differences are statistically significant. This naive look will let us drop clearly dominated cells where higher cost is associated with a lower quit rate, as well as any cells that proved infeasible in the clinical setting. In a refined pass, we will define incremental component cost effectiveness as ΔC/ΔE, where ΔC is the cost a component adds and ΔE is the effectiveness associated with the component. This refined look at the remaining candidates will use 2 effectiveness measures, the 3-month quit rate and the simulated quality-adjusted life year (QALY) gain. A QALY is a standard measure of health-related quality of life, defined so that a year in perfect health is valued at 1.0 and death is valued at 0.0 [<xref rid="R46" ref-type="bibr">46</xref>]. Even if 1 component costs more per quitter than another, it still may be worthwhile if it helps more smokers to quit at an acceptable cost per QALY gained. By estimating QALYs gained per quitter, we get a measure that lets us judge the cost of cessation gains relative to other smoking interventions, with a tentative ceiling of $5000 per QALY gained that we will refine in year 4 by updating our literature review on cessation interventions regularly used in medical settings.</p>
                  <p id="P39">The analysis will require estimates of the QALY losses and medical costs averted by smoking cessation. For QALY loss, the most recent estimates [<xref rid="R51" ref-type="bibr">51</xref>–<xref rid="R53" ref-type="bibr">53</xref>] are better than older estimates [<xref rid="R54" ref-type="bibr">54</xref>,<xref rid="R55" ref-type="bibr">55</xref>]. For medical costs, we expect to use the latest update to CDC’s SAMMEC model [<xref rid="R1" ref-type="bibr">1</xref>] which builds from the methods pioneered by V. Miller [<xref rid="R56" ref-type="bibr">56</xref>]. We will inflate all cost savings to the same year’s dollars as the program costs and compute present value of savings in future years at a 3% discount rate. To account for relapse, we will insert our chosen smoking costs and our observed quit rate pattern into the widely used BENESCO (benefits of smoking cessation on outcomes) Markov simulation model of cessation duration or a closely related model [<xref rid="R47" ref-type="bibr">47</xref>,<xref rid="R48" ref-type="bibr">48</xref>]. These models stem from a 2002 World Health Organization model. The resulting estimates will let us answer the question of which efficacious ED-based interventions maximize quits while staying below the acceptable cost per QALY gained.</p>
                  <p id="P40">To better inform our package choice, we will estimate 95% CIs around the ICERs. To estimate ratio variance, we will start with roughly estimated standard errors or distributional data for each number in the cost-effectiveness equation. We will use bootstrapping simulation methods that form an empirical probability distribution [<xref rid="R57" ref-type="bibr">57</xref>]. To handle estimates with unknown variance, notably the discount rate, we will conduct sensitivity analyses. The sensitivity analyses examine if different input assumptions would change package selection.</p>
                </sec>
              </sec>
              <sec id="S31">
                <title>2.13. Assessing feasibility, acceptability</title>
                <p id="P41">A novel feature of this study is the prespecified use of qualitative methods to assess the intervention. The goal of this analysis is to ensure that intervention components are considered feasible, practical, and acceptable by the patients who may use the package in real-world settings.</p>
                <p id="P42">Similar to our approach in the pilot study, we will conduct phone-based, semi-structured interviews with a sub-sample of participants at the 3-month follow-up assessment. The interview will begin with a set of items that use a Likert format to obtain an overall rating of each component that participants received, both alone and in combination. We will use a purposive sampling strategy that will recruit equal numbers of participants from each component (i.e., either as a single component or in combination) to allow us to explore potential interactions of components. Consent for the qualitative component will have already been given at study enrollment. The semi-structured interviews will be audio-recorded and subsequently transcribed and analyzed thematically, Recruitment will continue until thematic saturation has been achieved.</p>
                <p id="P43">Components scoring well in Likert assessments and found feasible and acceptable in interviews with participants (that are also clinically efficacious and cost-effective) will be retained to study in the future randomized trial.</p>
                <p id="P44">The semi-structured interviews will be audio-recorded and subsequently transcribed, coded by study personnel with experience in coding, and analyzed thematically in an ongoing and iterative process [<xref rid="R58" ref-type="bibr">58</xref>,<xref rid="R59" ref-type="bibr">59</xref>] using qualitative analysis software ATLAS.ti (version 7.0; ATLAS. ti GmbH). Recruitment will continue until thematic saturation has been achieved. We anticipate interviewing 80–100 participants.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="S32">
              <title>3. Results</title>
              <p id="P45">As of 12 July 2017, 203 participants have enrolled in the trial. Their median age is 44 years (SD 12.6); 101 (50%) are male; their racial and ethnic composition is 97 (48%) white, 70 (34%) African American, and 36 (18%) other. Thirty-three (16%) participants identify as Hispanic. Their insurance coverage is 127 (63%) Medicaid, 6 (3%) Medicare, 20 (10%) Medicaid and Medicare, 47 (23%) private insurance, and 3 (1%) uninsured. Recruitment is proceeding on schedule. One-month and threemonth follow-ups have begun, including the qualitative interviews.</p>
            </sec>
            <sec sec-type="discussion" id="S33">
              <title>4. Discussion</title>
              <p id="P46">Interventions for addictive disorders commonly employ both behavioral approaches and pharmacotherapy. Evidence-based behavioral approaches may include motivational interviewing/enhancement, cognitive behavioral therapy, group approaches, or technology-facilitated approaches such as telephone quitlines, web-based programs, and text messaging. Pharmacotherapies for tobacco dependence include nicotine patch, gum, lozenge, nasal spray, inhaler, as well as varenicline and buproprion [<xref rid="R29" ref-type="bibr">29</xref>]. This study addresses the significant challenge of deciding how to best treat tobacco dependence in the ED where low income smokers typically get treated.</p>
              <p id="P47">It is common to treat behavioral disorders and addictions with multi-component approaches. Given the complex behavioral, genetic, physiologic, and environmental factors that mediate disorders such as addiction, it is perhaps unsurprising that combinations of treatments often work better than monotherapy. Traditional approaches to assess efficacy typically involve randomized trials with two or more arms that test a package of interventions against control, or usual care. An important shortcoming of this approach is that it does not enable the investigator to disaggregate the effects of individual interventions or examine whether important interactions exist between interventions.</p>
              <p id="P48">This study offers innovation on a number of fronts: (1) this is the first study to assess the efficacy of the individual components of EDinitiated tobacco dependence treatment; (2) this is the first ED-based study to use the MOST clinical trial methodology; (3) this is the first large study in the ED of mobile health technology for tobacco dependence treatment; (4) the treatment paradigm initiates NRT at the time of enrollment, without the traditional 2–3 week period prior to a formal “quit date;” (5) to our knowledge, this is the first MOST trial to add a qualitative component to the analytic strategy, incorporating qualitative and quantitative assessments of efficacy, cost effectiveness, and feasibility/acceptability, using a concurrent triangulation mixed methods approach [<xref rid="R60" ref-type="bibr">60</xref>].</p>
            </sec>
            <sec sec-type="conclusions" id="S34">
              <title>5. Conclusion</title>
              <p id="P49">This study is a full-factorial 16-arm trial using the MOST design to assess the effects of 4 evidence-based therapies in the treatment of tobacco dependence among adult smokers visiting a hospital ED. The therapies are nicotine patches and gum, brief motivational interviewing, telephone-based quitline counseling, and text messaging. The study uses a mixed methods approach to identify the most efficacious combination of treatments within a fixed cost constraint. Study endpoints include assessments of clinical efficacy (i.e. biochemically verified smoking cessation at 3 months), cost effectiveness analysis, and acceptability of the interventions to study participants. Recruitment of 1056 participants will conclude approximately in February 2019. Once the optimal combination of interventions is identified, a follow-on clinical trial will assess its efficacy.</p>
            </sec>
          </body>
          <back>
            <ack id="S35">
              <p>
                <bold>Funding</bold>
              </p>
              <p>The study is supported by Grant R01CA201873 from the National Cancer Institute of the National Institutes of Health. The funder played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.</p>
              <p>The authors thank Teresa O’Leary and Kimberly Beauchemin for their excellent research assistance.</p>
            </ack>
            <fn-group>
              <fn id="FN2">
                <p>Trial registration: Trial (NCT02896400) registered in ClinicalTrials.gov on September 6, 2016.</p>
              </fn>
              <fn id="FN3">
                <p>
                  <bold>Ethics approval and consent to participate</bold>
                </p>
                <p>This study was approved by the Human Investigation Committee of Yale University. All participants will provide written informed consent before participating.</p>
              </fn>
              <fn id="FN4">
                <p>
                  <bold>Consent for publication</bold>
                </p>
                <p>Not applicable.</p>
              </fn>
              <fn id="FN5">
                <p>
                  <bold>Availability of data and material</bold>
                </p>
                <p>Not applicable.</p>
              </fn>
              <fn fn-type="COI-statement" id="FN6">
                <p>
                  <bold>Competing interests</bold>
                </p>
                <p>Dr. Toll received a grant from Pfizer for medicine only, and he testifies as an expert witness for plaintiffs who have filed litigation against the tobacco companies.</p>
                <p>All other authors declare that they have no competing interests.</p>
              </fn>
              <fn id="FN7" fn-type="con">
                <p>
                  <bold>Authors’ contributions</bold>
                </p>
                <p>SLB conceived of the study and wrote the first draft of the manuscript. BT, LC, LA, MP, TM, KV, and LG contributed to study design. JD directs the statistical analysis. JW manages the study. All authors read and approved the final manuscript.</p>
              </fn>
            </fn-group>
            <ref-list>
              <ref id="R1">
                <label>1</label>
                <element-citation publication-type="book">
                  <collab>U.S. Department of Health and Human Services</collab>
                  <article-title>The health consequences of smoking— 50 years of progress</article-title>
                  <source>A report of the surgeon general</source>
                  <publisher-name>U.S. Department of Health and Human Services CfDCaP, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health</publisher-name>
                  <publisher-loc>Atlanta, GA</publisher-loc>
                  <year>2014</year>
                </element-citation>
              </ref>
              <ref id="R2">
                <label>2</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jamal</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>King</surname>
                      <given-names>BA</given-names>
                    </name>
                    <name>
                      <surname>Neff</surname>
                      <given-names>LJ</given-names>
                    </name>
                    <name>
                      <surname>Whitmill</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Babb</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Graffunder</surname>
                      <given-names>CM</given-names>
                    </name>
                  </person-group>
                  <article-title>Current cigarette smoking among adults — United States, 2005–2015</article-title>
                  <source>MMWR Morb Mortal Wkly Rep</source>
                  <volume>65</volume>
                  <year>2016</year>
                  <fpage>1205</fpage>
                  <lpage>1211</lpage>
                  <pub-id pub-id-type="doi">10.15585/mmwr.mm6544a2</pub-id>
                  <pub-id pub-id-type="pmid">27832052</pub-id>
                </element-citation>
              </ref>
              <ref id="R3">
                <label>3</label>
                <element-citation publication-type="book">
                  <collab>Office of Disease Prevention and Health Promotion</collab>
                  <source>Tobacco Use: Objectives</source>
                  <date-in-citation>Accessed 15 December 2014</date-in-citation>
                  <comment>
                    <ext-link ext-link-type="uri" xlink:href="https://www.healthypeople.gov/2020/topicsobjectives/topic/tobacco-use/objectives">https://www.healthypeople.gov/2020/topicsobjectives/topic/tobacco-use/objectives</ext-link>
                  </comment>
                  <publisher-name>U.S. Department of Health and Human Services</publisher-name>
                  <year>2010</year>
                </element-citation>
              </ref>
              <ref id="R4">
                <label>4</label>
                <element-citation publication-type="journal">
                  <collab>NIH State-of-the-Science Panel</collab>
                  <article-title>National Institutes of Health state-of-the-science conference statement: tobacco use: prevention, cessation, and control</article-title>
                  <source>Ann Intern Med</source>
                  <volume>145</volume>
                  <year>2006</year>
                  <fpage>839</fpage>
                  <lpage>844</lpage>
                  <pub-id pub-id-type="pmid">16954353</pub-id>
                </element-citation>
              </ref>
              <ref id="R5">
                <label>5</label>
                <element-citation publication-type="web">
                  <collab>Centers for Disease Control and Prevention, National Hospital Ambulatory Medical Care Survey</collab>
                  <source>Emergency Department Summary Tables</source>
                  <year>2011</year>
                  <date-in-citation>Accessed 15 December 2014</date-in-citation>
                  <comment>at <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/nchs/data/ahcd/nhamcs_emergency/2011_ed_web_tables.pdf">http://www.cdc.gov/nchs/data/ahcd/nhamcs_emergency/2011_ed_web_tables.pdf</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="R6">
                <label>6</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lowenstein</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Tomlinson</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Koziol-McLain</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Prochazka</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Smoking habits of emergency department patients: an opportunity for disease prevention</article-title>
                  <source>Acad Emerg Med</source>
                  <volume>2</volume>
                  <year>1995</year>
                  <fpage>165</fpage>
                  <lpage>171</lpage>
                  <pub-id pub-id-type="pmid">7497028</pub-id>
                </element-citation>
              </ref>
              <ref id="R7">
                <label>7</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lowenstein</surname>
                      <given-names>SR</given-names>
                    </name>
                    <name>
                      <surname>Koziol-McLain</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Thompson</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Behavioral risk factors in emergency department patients: a multisite study</article-title>
                  <source>Acad Emerg Med</source>
                  <volume>5</volume>
                  <year>1998</year>
                  <fpage>781</fpage>
                  <lpage>787</lpage>
                  <pub-id pub-id-type="pmid">9715239</pub-id>
                </element-citation>
              </ref>
              <ref id="R8">
                <label>8</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bernstein</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Bijur</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Cooperman</surname>
                      <given-names>N</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A randomized trial of a multicomponent cessation strategy for emergency department smokers</article-title>
                  <source>Acad Emerg Med</source>
                  <volume>18</volume>
                  <year>2011</year>
                  <fpage>575</fpage>
                  <lpage>583</lpage>
                  <pub-id pub-id-type="pmid">21676054</pub-id>
                </element-citation>
              </ref>
              <ref id="R9">
                <label>9</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bernstein</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Arnsten</surname>
                      <given-names>JH</given-names>
                    </name>
                    <name>
                      <surname>Bijur</surname>
                      <given-names>PE</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Concurrent use of alcohol or illicit substances improves response to ED SBIRT for adult smokers</article-title>
                  <source>J Subst Abus Treat</source>
                  <volume>44</volume>
                  <year>2013</year>
                  <fpage>139</fpage>
                  <lpage>142</lpage>
                </element-citation>
              </ref>
              <ref id="R10">
                <label>10</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bernstein</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>D’Onofrio</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Rosner</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Successful tobacco dependence treatment achieved via pharmacotherapy and motivational interviewing in low-income emergency department patients</article-title>
                  <source>Ann Emerg Med</source>
                  <volume>66</volume>
                  <year>2015</year>
                  <fpage>140</fpage>
                  <lpage>147</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.annemergmed.2015.03.030</pub-id>
                  <pub-id pub-id-type="pmid">25920384</pub-id>
                </element-citation>
              </ref>
              <ref id="R11">
                <label>11</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Boudreaux</surname>
                      <given-names>ED</given-names>
                    </name>
                    <name>
                      <surname>Baumann</surname>
                      <given-names>BM</given-names>
                    </name>
                    <name>
                      <surname>Camargo</surname>
                      <given-names>CA</given-names>
                      <suffix>Jr</suffix>
                    </name>
                    <name>
                      <surname>O’Hea</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Ziedonis</surname>
                      <given-names>DM</given-names>
                    </name>
                  </person-group>
                  <article-title>Changes in smoking associated with an acute health event: theoretical and practical implications</article-title>
                  <source>Ann Behav Med</source>
                  <volume>33</volume>
                  <year>2007</year>
                  <fpage>189</fpage>
                  <lpage>199</lpage>
                  <pub-id pub-id-type="pmid">17447871</pub-id>
                </element-citation>
              </ref>
              <ref id="R12">
                <label>12</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bernstein</surname>
                      <given-names>SL</given-names>
                    </name>
                  </person-group>
                  <article-title>Tobacco-related illnesses and management</article-title>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Todd</surname>
                      <given-names>KH</given-names>
                    </name>
                    <name>
                      <surname>Thomas</surname>
                      <given-names>CR</given-names>
                      <suffix>Jr</suffix>
                    </name>
                  </person-group>
                  <source>Oncologic Emergency Medicine: Principles and Practice</source>
                  <publisher-name>Springer</publisher-name>
                  <publisher-loc>Switzerland</publisher-loc>
                  <year>2016</year>
                </element-citation>
              </ref>
              <ref id="R13">
                <label>13</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Babor</surname>
                      <given-names>TF</given-names>
                    </name>
                    <name>
                      <surname>McRee</surname>
                      <given-names>BG</given-names>
                    </name>
                    <name>
                      <surname>Kassebaum</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Grimaldi</surname>
                      <given-names>PL</given-names>
                    </name>
                    <name>
                      <surname>Ahmed</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Bray</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Screening, brief intervention, and referral to treatment (SBIRT)</article-title>
                  <source>Subst Abus</source>
                  <volume>28</volume>
                  <year>2007</year>
                  <fpage>7</fpage>
                  <lpage>30</lpage>
                  <pub-id pub-id-type="pmid">18077300</pub-id>
                </element-citation>
              </ref>
              <ref id="R14">
                <label>14</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>D’Onofrio</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Fiellin</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Pantalon</surname>
                      <given-names>MV</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A brief intervention reduces hazardous and harmful drinking in emergency department patients</article-title>
                  <source>Ann Emerg Med</source>
                  <volume>60</volume>
                  <year>2012</year>
                  <fpage>181</fpage>
                  <lpage>192</lpage>
                  <pub-id pub-id-type="pmid">22459448</pub-id>
                </element-citation>
              </ref>
              <ref id="R15">
                <label>15</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bernstein</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Rosner</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Toll</surname>
                      <given-names>B</given-names>
                    </name>
                  </person-group>
                  <article-title>A multicomponent intervention including texting to promote tobacco abstinence in emergency department smokers: a pilot study</article-title>
                  <source>Acad Emerg Med</source>
                  <volume>23</volume>
                  <year>2016</year>
                  <fpage>803</fpage>
                  <lpage>808</lpage>
                  <pub-id pub-id-type="doi">10.1111/acem.12990</pub-id>
                  <pub-id pub-id-type="pmid">27146116</pub-id>
                </element-citation>
              </ref>
              <ref id="R16">
                <label>16</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grau</surname>
                      <given-names>LE</given-names>
                    </name>
                    <name>
                      <surname>Pham</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>O’Leary</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Rosner</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Toll</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Bernstein</surname>
                      <given-names>SL</given-names>
                    </name>
                  </person-group>
                  <article-title>Smokers’ perspectives on texting for tobacco dependence treatment: a qualitative analysis</article-title>
                  <source>Nicotine Tob Res</source>
                  <volume>19</volume>
                  <year>2017</year>
                  <fpage>307</fpage>
                  <lpage>313</lpage>
                  <pub-id pub-id-type="pmid">27613935</pub-id>
                </element-citation>
              </ref>
              <ref id="R17">
                <label>17</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Collins</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Dziak</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Kugler</surname>
                      <given-names>KC</given-names>
                    </name>
                    <name>
                      <surname>Trail</surname>
                      <given-names>JB</given-names>
                    </name>
                  </person-group>
                  <article-title>Factorial experiments: efficient tools for evaluation of intervention components</article-title>
                  <source>Am J Prev Med</source>
                  <volume>47</volume>
                  <year>2014</year>
                  <fpage>498</fpage>
                  <lpage>504</lpage>
                  <pub-id pub-id-type="pmid">25092122</pub-id>
                </element-citation>
              </ref>
              <ref id="R18">
                <label>18</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Collins</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Dziak</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Design of experiments with multiple independent variables: a resource management perspective on complete and reduced factorial designs</article-title>
                  <source>Psychol Methods</source>
                  <volume>14</volume>
                  <year>2009</year>
                  <fpage>202</fpage>
                  <lpage>224</lpage>
                  <pub-id pub-id-type="pmid">19719358</pub-id>
                </element-citation>
              </ref>
              <ref id="R19">
                <label>19</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Collins</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>MacKinnon</surname>
                      <given-names>DP</given-names>
                    </name>
                    <name>
                      <surname>Reeve</surname>
                      <given-names>BB</given-names>
                    </name>
                  </person-group>
                  <article-title>Some methodological considerations in theory-based health behavior research</article-title>
                  <source>Health Psychol</source>
                  <volume>32</volume>
                  <year>2013</year>
                  <fpage>586</fpage>
                  <lpage>591</lpage>
                  <pub-id pub-id-type="pmid">23646842</pub-id>
                </element-citation>
              </ref>
              <ref id="R20">
                <label>20</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Collins</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Murphy</surname>
                      <given-names>SA</given-names>
                    </name>
                    <name>
                      <surname>Nair</surname>
                      <given-names>VN</given-names>
                    </name>
                    <name>
                      <surname>Strecher</surname>
                      <given-names>VJ</given-names>
                    </name>
                  </person-group>
                  <article-title>A strategy for optimizing and evaluating behavioral interventions</article-title>
                  <source>Ann Behav Med</source>
                  <volume>30</volume>
                  <year>2005</year>
                  <fpage>65</fpage>
                  <lpage>73</lpage>
                  <pub-id pub-id-type="pmid">16097907</pub-id>
                </element-citation>
              </ref>
              <ref id="R21">
                <label>21</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Collins</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Murphy</surname>
                      <given-names>SA</given-names>
                    </name>
                    <name>
                      <surname>Strecher</surname>
                      <given-names>V</given-names>
                    </name>
                  </person-group>
                  <article-title>The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART): new methods for more potent eHealth interventions</article-title>
                  <source>Am J Prev Med</source>
                  <volume>32</volume>
                  <year>2007</year>
                  <fpage>S112</fpage>
                  <lpage>118</lpage>
                  <pub-id pub-id-type="pmid">17466815</pub-id>
                </element-citation>
              </ref>
              <ref id="R22">
                <label>22</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McClure</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Derry</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Riggs</surname>
                      <given-names>KR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Questions about quitting (Q2): design and methods of a Multiphase Optimization Strategy (MOST) randomized screening experiment for an online, motivational smoking cessation intervention</article-title>
                  <source>Contemp Clin Trials</source>
                  <volume>33</volume>
                  <year>2012</year>
                  <fpage>1094</fpage>
                  <lpage>1102</lpage>
                  <pub-id pub-id-type="pmid">22771577</pub-id>
                </element-citation>
              </ref>
              <ref id="R23">
                <label>23</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fraser</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Kobinsky</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>SS</given-names>
                    </name>
                    <name>
                      <surname>Kramer</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Theobald</surname>
                      <given-names>WE</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>TB</given-names>
                    </name>
                  </person-group>
                  <article-title>Five population-based interventions for smoking cessation: a MOST trial</article-title>
                  <source>Transl Behav Med</source>
                  <volume>4</volume>
                  <year>2014</year>
                  <fpage>382</fpage>
                  <lpage>390</lpage>
                  <pub-id pub-id-type="pmid">25584087</pub-id>
                </element-citation>
              </ref>
              <ref id="R24">
                <label>24</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baker</surname>
                      <given-names>TB</given-names>
                    </name>
                    <name>
                      <surname>Mermelstein</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Collins</surname>
                      <given-names>LM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>New methods for tobacco dependence treatment research</article-title>
                  <source>Ann Behav Med</source>
                  <volume>41</volume>
                  <year>2011</year>
                  <fpage>192</fpage>
                  <lpage>207</lpage>
                  <pub-id pub-id-type="pmid">21128037</pub-id>
                </element-citation>
              </ref>
              <ref id="R25">
                <label>25</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Collins</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>TB</given-names>
                    </name>
                    <name>
                      <surname>Mermelstein</surname>
                      <given-names>RJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The multiphase optimization strategy for engineering effective tobacco use interventions</article-title>
                  <source>Ann Behav Med</source>
                  <volume>41</volume>
                  <year>2011</year>
                  <fpage>208</fpage>
                  <lpage>226</lpage>
                  <pub-id pub-id-type="pmid">21132416</pub-id>
                </element-citation>
              </ref>
              <ref id="R26">
                <label>26</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Miller</surname>
                      <given-names>WR</given-names>
                    </name>
                    <name>
                      <surname>Rollnick</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <source>Motivational Interviewing: Preparing People for Change</source>
                  <edition>2</edition>
                  <publisher-name>Guilford Press</publisher-name>
                  <publisher-loc>New York</publisher-loc>
                  <year>2002</year>
                </element-citation>
              </ref>
              <ref id="R27">
                <label>27</label>
                <element-citation publication-type="web">
                  <collab>United States Census Bureau</collab>
                  <source>American Fact Finder</source>
                  <date-in-citation>Accessed 11 July 2017</date-in-citation>
                  <comment>
                    <ext-link ext-link-type="uri" xlink:href="https://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=CF2015">https://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=CF2015</ext-link>
                  </comment>
                  <year>2017</year>
                </element-citation>
              </ref>
              <ref id="R28">
                <label>28</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Abraham</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Buchanan</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <source>Greater New Haven Community Index 2016</source>
                  <date-in-citation>Accessed 2 January 2017</date-in-citation>
                  <comment>at <ext-link ext-link-type="uri" xlink:href="http://www.ctdatahaven.org/sites/ctdatahaven/files/DataHaven_GNH_Community_Index.pdf">http://www.ctdatahaven.org/sites/ctdatahaven/files/DataHaven_GNH_Community_Index.pdf</ext-link></comment>
                  <publisher-loc>New Haven, CT</publisher-loc>
                  <publisher-name>DataHaven</publisher-name>
                  <year>2016</year>
                </element-citation>
              </ref>
              <ref id="R29">
                <label>29</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fiore</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Jaén</surname>
                      <given-names>CR</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>TB</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <source>Treating Tobacco Use and Dependence: 2008 Update</source>
                  <publisher-loc>Rockville, MD</publisher-loc>
                  <publisher-name>US Department of Health and Human Services</publisher-name>
                  <year>2008</year>
                </element-citation>
              </ref>
              <ref id="R30">
                <label>30</label>
                <element-citation publication-type="web">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Whittaker</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>McRobbie</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Bullen</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Borland</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Rodgers</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Gu</surname>
                      <given-names>Y</given-names>
                    </name>
                  </person-group>
                  <article-title>Mobile Phone-based Interventions for Smoking Cessation</article-title>
                  <source>Cochrane Database of Systematic Reviews</source>
                  <year>2012</year>
                  <pub-id pub-id-type="doi">10.1002/14651858.CD006611.pub3</pub-id>
                </element-citation>
              </ref>
              <ref id="R31">
                <label>31</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stoyneva</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Coa</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Pugatch</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Sanders</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Schwarz</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Cole-Lewis</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>SmokefreeTXT behaviour change technique analysis</article-title>
                  <source>J Smok Cessat</source>
                  <year>2016</year>
                  <fpage>1</fpage>
                  <lpage>13</lpage>
                </element-citation>
              </ref>
              <ref id="R32">
                <label>32</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bandura</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Human agency in social cognitive theory</article-title>
                  <source>Am Psychol</source>
                  <volume>44</volume>
                  <year>1989</year>
                  <fpage>1175</fpage>
                  <lpage>1184</lpage>
                  <pub-id pub-id-type="pmid">2782727</pub-id>
                </element-citation>
              </ref>
              <ref id="R33">
                <label>33</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Orleans</surname>
                      <given-names>TC</given-names>
                    </name>
                    <name>
                      <surname>Schoenbach</surname>
                      <given-names>VJ</given-names>
                    </name>
                    <name>
                      <surname>Wagner</surname>
                      <given-names>EH</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Self-help quit smoking interventions: effects of self-help materials, social support instructions, and telephone counseling</article-title>
                  <source>J Consult Clin Psychol</source>
                  <volume>59</volume>
                  <year>1991</year>
                  <fpage>439</fpage>
                  <lpage>448</lpage>
                  <pub-id pub-id-type="pmid">2071729</pub-id>
                </element-citation>
              </ref>
              <ref id="R34">
                <label>34</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Swan</surname>
                      <given-names>GE</given-names>
                    </name>
                    <name>
                      <surname>McAfee</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Curry</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial</article-title>
                  <source>Arch Intern Med</source>
                  <volume>163</volume>
                  <year>2003</year>
                  <fpage>2337</fpage>
                  <lpage>2344</lpage>
                  <pub-id pub-id-type="pmid">14581254</pub-id>
                </element-citation>
              </ref>
              <ref id="R35">
                <label>35</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hollis</surname>
                      <given-names>JF</given-names>
                    </name>
                    <name>
                      <surname>McAfee</surname>
                      <given-names>TA</given-names>
                    </name>
                    <name>
                      <surname>Fellows</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Zbikowski</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Stark</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Riedlinger</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline</article-title>
                  <source>Tob Control</source>
                  <volume>16</volume>
                  <year>2007</year>
                  <fpage>i53</fpage>
                  <lpage>i59</lpage>
                  <pub-id pub-id-type="pmid">18048633</pub-id>
                </element-citation>
              </ref>
              <ref id="R36">
                <label>36</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Curry</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>Grothaus</surname>
                      <given-names>LC</given-names>
                    </name>
                    <name>
                      <surname>McAfee</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Pabinak</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization</article-title>
                  <source>N Engl J Med</source>
                  <volume>339</volume>
                  <year>1998</year>
                  <fpage>673</fpage>
                  <lpage>679</lpage>
                  <pub-id pub-id-type="pmid">9725926</pub-id>
                </element-citation>
              </ref>
              <ref id="R37">
                <label>37</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ringen</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Anderson</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>McAfee</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Zbikowski</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Fales</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <article-title>Smoking cessation in a blue-collar population: results from an evidence-based pilot program</article-title>
                  <source>Am J Ind Med</source>
                  <volume>42</volume>
                  <year>2002</year>
                  <fpage>367</fpage>
                  <lpage>377</lpage>
                  <pub-id pub-id-type="pmid">12382249</pub-id>
                </element-citation>
              </ref>
              <ref id="R38">
                <label>38</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>El-Bastawissi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>McAfee</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Zbikowski</surname>
                      <given-names>SM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The uninsured and Medicaid Oregon tobacco user experience in a real world, phone based cessation programme</article-title>
                  <source>Tob Control</source>
                  <volume>12</volume>
                  <year>2003</year>
                  <fpage>45</fpage>
                  <lpage>51</lpage>
                  <pub-id pub-id-type="pmid">12612361</pub-id>
                </element-citation>
              </ref>
              <ref id="R39">
                <label>39</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bernstein</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Weiss</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Toll</surname>
                      <given-names>BA</given-names>
                    </name>
                    <name>
                      <surname>Zbikowski</surname>
                      <given-names>SM</given-names>
                    </name>
                  </person-group>
                  <article-title>Association between utilization of quitline services and probability of tobacco abstinence in low-income smokers</article-title>
                  <source>J Subst Abuse Treat</source>
                  <volume>71</volume>
                  <year>2016</year>
                  <fpage>58</fpage>
                  <lpage>62</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jsat.2016.08.014</pub-id>
                  <pub-id pub-id-type="pmid">27776679</pub-id>
                </element-citation>
              </ref>
              <ref id="R40">
                <label>40</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hughes</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Keely</surname>
                      <given-names>JP</given-names>
                    </name>
                    <name>
                      <surname>Niaura</surname>
                      <given-names>RS</given-names>
                    </name>
                    <name>
                      <surname>Ossip-Klein</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Richmond</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Swan</surname>
                      <given-names>GE</given-names>
                    </name>
                  </person-group>
                  <article-title>Measures of abstinence in clinical trials: issues and recommendations</article-title>
                  <source>Nicotine Tob Res</source>
                  <volume>5</volume>
                  <year>2003</year>
                  <fpage>13</fpage>
                  <lpage>25</lpage>
                  <pub-id pub-id-type="pmid">12745503</pub-id>
                </element-citation>
              </ref>
              <ref id="R41">
                <label>41</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McLellan</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Alterman</surname>
                      <given-names>AI</given-names>
                    </name>
                    <name>
                      <surname>Cacciloa</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Metzger</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>O’Brien</surname>
                      <given-names>CP</given-names>
                    </name>
                  </person-group>
                  <article-title>A new measure of substance abuse treatment: initial studies of the treatment service review</article-title>
                  <source>J Nerv Ment Dis</source>
                  <volume>180</volume>
                  <year>1992</year>
                  <fpage>101</fpage>
                  <lpage>110</lpage>
                  <pub-id pub-id-type="pmid">1737971</pub-id>
                </element-citation>
              </ref>
              <ref id="R42">
                <label>42</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Efron</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Tibshirani</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <source>An Introduction to the Bootstrap</source>
                  <publisher-name>Chapman &amp; Hall/CRC</publisher-name>
                  <publisher-loc>Boca Raton, FL</publisher-loc>
                  <year>1993</year>
                </element-citation>
              </ref>
              <ref id="R43">
                <label>43</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dmitrienko</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Molenberghs</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Chuang-Stein</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Offen</surname>
                      <given-names>W</given-names>
                    </name>
                  </person-group>
                  <source>Analysis of Clinical Trials Using SAS: A Practical Guide</source>
                  <publisher-name>SAS Institute, Inc</publisher-name>
                  <publisher-loc>Cary, NC</publisher-loc>
                  <year>2005</year>
                </element-citation>
              </ref>
              <ref id="R44">
                <label>44</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wolbers</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Heemskerk</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Chau</surname>
                      <given-names>T</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Sample size requirements for separating out the effects of combination treatments: randomised controlled trials of combination therapy vs. standard treatment compared to factorial designs for patients with tuberculous meningitis</article-title>
                  <source>Trials</source>
                  <volume>12</volume>
                  <issue>26</issue>
                  <year>2011</year>
                </element-citation>
              </ref>
              <ref id="R45">
                <label>45</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Drummond</surname>
                      <given-names>MF</given-names>
                    </name>
                    <name>
                      <surname>Schulpher</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Torrance</surname>
                      <given-names>GW</given-names>
                    </name>
                    <name>
                      <surname>O’Brien</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Stoddart</surname>
                      <given-names>GL</given-names>
                    </name>
                  </person-group>
                  <source>Methods for the Economic Evaluation of Health Care Programmes</source>
                  <edition>3</edition>
                  <publisher-name>Oxford University Press</publisher-name>
                  <publisher-loc>New York</publisher-loc>
                  <year>2007</year>
                </element-citation>
              </ref>
              <ref id="R46">
                <label>46</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gold</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Siegel</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Russell</surname>
                      <given-names>LB</given-names>
                    </name>
                    <name>
                      <surname>Weinstein</surname>
                      <given-names>MC</given-names>
                    </name>
                  </person-group>
                  <source>Cost-Effectiveness in Health and Medicine</source>
                  <publisher-name>Oxford University Press</publisher-name>
                  <publisher-loc>New York</publisher-loc>
                  <year>1996</year>
                </element-citation>
              </ref>
              <ref id="R47">
                <label>47</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Howard</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Knight</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Boler</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO simulation model: application to a population of US adult smokers</article-title>
                  <source>PharmacoEconomics</source>
                  <volume>26</volume>
                  <year>2008</year>
                  <fpage>497</fpage>
                  <lpage>511</lpage>
                  <pub-id pub-id-type="pmid">18489200</pub-id>
                </element-citation>
              </ref>
              <ref id="R48">
                <label>48</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Flack</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Taylor</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Trueman</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <source>Cost-effectiveness of Interventions for Smoking Cessation: Final Report</source>
                  <publisher-name>National Institute for Health and Clinical Excellence</publisher-name>
                  <publisher-loc>London</publisher-loc>
                  <year>2007</year>
                </element-citation>
              </ref>
              <ref id="R49">
                <label>49</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cromwell</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Bartosch</surname>
                      <given-names>WJ</given-names>
                    </name>
                    <name>
                      <surname>Fiore</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Hasselblad</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>T</given-names>
                    </name>
                  </person-group>
                  <article-title>Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research, see comment</article-title>
                  <source>JAMA</source>
                  <volume>278</volume>
                  <year>1997</year>
                  <fpage>1759</fpage>
                  <lpage>1766</lpage>
                  <pub-id pub-id-type="pmid">9388153</pub-id>
                </element-citation>
              </ref>
              <ref id="R50">
                <label>50</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Levy</surname>
                      <given-names>DT</given-names>
                    </name>
                    <name>
                      <surname>Graham</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Mabry</surname>
                      <given-names>PL</given-names>
                    </name>
                    <name>
                      <surname>Abrams</surname>
                      <given-names>DB</given-names>
                    </name>
                    <name>
                      <surname>Orleans</surname>
                      <given-names>CT</given-names>
                    </name>
                  </person-group>
                  <article-title>Modeling the impact of smoking-cessation treatment policies on quit rates</article-title>
                  <source>Am J Prev Med</source>
                  <volume>38</volume>
                  <year>2010</year>
                  <fpage>S364</fpage>
                  <lpage>S372</lpage>
                  <pub-id pub-id-type="pmid">20176309</pub-id>
                </element-citation>
              </ref>
              <ref id="R51">
                <label>51</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jia</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Lubetkin</surname>
                      <given-names>EI</given-names>
                    </name>
                  </person-group>
                  <article-title>Trends in quality-adjusted life-years lost contributed by smoking and obesity</article-title>
                  <source>Am J Prev Med</source>
                  <volume>38</volume>
                  <year>2010</year>
                  <fpage>138</fpage>
                  <lpage>144</lpage>
                  <pub-id pub-id-type="pmid">20117569</pub-id>
                </element-citation>
              </ref>
              <ref id="R52">
                <label>52</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Strine</surname>
                      <given-names>TW</given-names>
                    </name>
                    <name>
                      <surname>Okoro</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Chapman</surname>
                      <given-names>DP</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Health-related quality of life and health risk behaviors among smokers</article-title>
                  <source>Am J Prev Med</source>
                  <volume>28</volume>
                  <year>2005</year>
                  <fpage>182</fpage>
                  <lpage>187</lpage>
                  <pub-id pub-id-type="pmid">15710274</pub-id>
                </element-citation>
              </ref>
              <ref id="R53">
                <label>53</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vogl</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Wenig</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Leidl</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Pokhrel</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Smoking and health-related quality of life in English general population: implications for economic evaluations</article-title>
                  <source>BMC Public Health</source>
                  <volume>19</volume>
                  <issue>203</issue>
                  <year>2012</year>
                </element-citation>
              </ref>
              <ref id="R54">
                <label>54</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ahmad</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Billimek</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Estimating the health impacts of tobacco harm reduction policies: a simulation modeling approach</article-title>
                  <source>Risk Anal</source>
                  <volume>25</volume>
                  <year>2005</year>
                  <fpage>801</fpage>
                  <lpage>812</lpage>
                  <pub-id pub-id-type="pmid">16268930</pub-id>
                </element-citation>
              </ref>
              <ref id="R55">
                <label>55</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Glick</surname>
                      <given-names>HA</given-names>
                    </name>
                    <name>
                      <surname>Doshi</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Sonnad</surname>
                      <given-names>SS</given-names>
                    </name>
                    <name>
                      <surname>Polsky</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <source>Economic Evaluation in Clinical Trials</source>
                  <publisher-name>Oxford University Press</publisher-name>
                  <publisher-loc>Oxford</publisher-loc>
                  <year>2007</year>
                </element-citation>
              </ref>
              <ref id="R56">
                <label>56</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Miller</surname>
                      <given-names>VP</given-names>
                    </name>
                    <name>
                      <surname>Ernst</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Collin</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>Smoking-attributable medical care costs in the USA</article-title>
                  <source>Soc Sci Med</source>
                  <volume>48</volume>
                  <year>1999</year>
                  <fpage>375</fpage>
                  <lpage>391</lpage>
                  <pub-id pub-id-type="pmid">10077285</pub-id>
                </element-citation>
              </ref>
              <ref id="R57">
                <label>57</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Willan</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>Briggs</surname>
                      <given-names>AH</given-names>
                    </name>
                  </person-group>
                  <source>Statistical Analysis of Cost-effectiveness Data</source>
                  <publisher-name>John Wiley &amp; Sons Ltd</publisher-name>
                  <publisher-loc>West Sussex, UK</publisher-loc>
                  <year>2006</year>
                </element-citation>
              </ref>
              <ref id="R58">
                <label>58</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Braun</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Clarke</surname>
                      <given-names>V</given-names>
                    </name>
                  </person-group>
                  <article-title>Using thematic analysis in psychology</article-title>
                  <source>Qual Res Psychol</source>
                  <volume>3</volume>
                  <year>2006</year>
                  <fpage>77</fpage>
                  <lpage>101</lpage>
                </element-citation>
              </ref>
              <ref id="R59">
                <label>59</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Braun</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Clarke</surname>
                      <given-names>V</given-names>
                    </name>
                  </person-group>
                  <source>Successful Qualitative Research: A Practical Guide for Beginners</source>
                  <publisher-name>SAGE Publications Ltd</publisher-name>
                  <publisher-loc>Thousand Oaks, CA</publisher-loc>
                  <year>2013</year>
                </element-citation>
              </ref>
              <ref id="R60">
                <label>60</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cresswell</surname>
                      <given-names>JW</given-names>
                    </name>
                    <name>
                      <surname>Clark</surname>
                      <given-names>VLP</given-names>
                    </name>
                    <name>
                      <surname>Gutmann</surname>
                      <given-names>ML</given-names>
                    </name>
                    <name>
                      <surname>Hanson</surname>
                      <given-names>WE</given-names>
                    </name>
                  </person-group>
                  <article-title>Advanced mixed methods research designs</article-title>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Tashakkori</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Teddlie</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <source>Handbook of Mixed Methods in Social &amp; Behavioral Research</source>
                  <publisher-name>SAGE Publications, Inc</publisher-name>
                  <publisher-loc>Thousand Oaks, CA</publisher-loc>
                  <year>2003</year>
                </element-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig id="F1" orientation="portrait" position="float">
              <label>Fig. 1</label>
              <caption>
                <p>Multiphase Optimization Strategy (MOST).</p>
              </caption>
              <graphic xlink:href="nihms949705f1"/>
            </fig>
            <fig id="F2" orientation="portrait" position="float">
              <label>Fig. 2</label>
              <caption>
                <p>Schematic view of analytic strategy after factorial trial.</p>
              </caption>
              <graphic xlink:href="nihms949705f2"/>
            </fig>
            <table-wrap id="T1" position="float" orientation="portrait">
              <label>Table 1</label>
              <caption>
                <p>Arms of the trial.</p>
              </caption>
              <table frame="box" rules="all">
                <thead>
                  <tr>
                    <th valign="bottom" align="left" rowspan="1" colspan="1">Arm</th>
                    <th valign="bottom" align="center" rowspan="1" colspan="1">BNI</th>
                    <th valign="bottom" align="center" rowspan="1" colspan="1">NRT</th>
                    <th valign="bottom" align="center" rowspan="1" colspan="1">QL</th>
                    <th valign="bottom" align="center" rowspan="1" colspan="1">Text</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">1</td>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">2</td>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">3</td>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">4</td>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">5</td>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">6</td>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">7</td>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">8</td>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">9</td>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">11</td>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">12</td>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">13</td>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">14</td>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">15</td>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#92D050" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">16</td>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                    <td align="center" valign="top" content-type="background-color:#FF0000" rowspan="1" colspan="1"/>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN1">
                  <p>Green =component is offered.</p>
                </fn>
                <fn id="TFN2">
                  <p>Red = component is not.</p>
                </fn>
                <fn id="TFN3">
                  <p>BNI =Brief negotiated interview.</p>
                </fn>
                <fn id="TFN4">
                  <p>NRT = Nicotine replacement therapy.</p>
                </fn>
                <fn id="TFN5">
                  <p>QL = Quitline referral.</p>
                </fn>
                <fn id="TFN6">
                  <p>Text =Smoke-free text.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap id="T2" position="float" orientation="portrait">
              <label>Table 2</label>
              <caption>
                <p>Components of economic analysis.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th valign="bottom" align="left" rowspan="1" colspan="1">Component</th>
                    <th valign="bottom" align="left" rowspan="1" colspan="1">Health system cost</th>
                    <th valign="bottom" align="left" rowspan="1" colspan="1">Participant cost</th>
                    <th valign="bottom" align="left" rowspan="1" colspan="1">State costs</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Screening</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">None. Screening information collected for all patients.</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">None.</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">None.</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Motivational interview</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Provider time performing motivational interview (wage × minutes). Average YNHH wage, conditional on provider training (i.e., MD, nurse practitioner, RA) will be used.</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">None. No additional time in hospital due to motivational interview.</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">None.</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Medication (6 weeks)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Total price paid by hospital. In sensitivity analysis we will consider average wholesale price (AWP), since not all providers receive same medication discounts.</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">None. Assume all costs of medication borne by provider.</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">None.</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Quitline</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">None. Provider bears no costs for quit line use.</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Cost of time on QL (avg. wage rate ×min/call).</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Marginal cost of QL user.</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Texting</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">None. Texting will be automated. Once developed marginal cost of texting is small.</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Cost of minutes to participant.</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">None.</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Brochure</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">Printing costs of brochure.</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">None.</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">None.</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
